Carefully designed and rigorously implemented monitoring and evaluation systems are key to tracking progress toward trachoma and lymphatic filariasis elimination goals. To reinforce national systems, the MMDP Project builds upon each country’s existing data collection and reporting tools, providing technical support in the collection and interpretation of data used by countries to guide their disease elimination programs.
Data for the project are collected through national reporting systems and tools, beginning at the point of service and moving through the national reporting system to the central level. MMDP Project teams work with the ministry of health in each project country to report semiannually on indicators that align with the World Health Organization’s criteria for demonstrating elimination of trachoma and lymphatic filariasis.
The MMDP Project is pioneering specially designed tools and supporting robust data collection and reporting systems to ensure that project beneficiaries receive the highest quality services, and that MMDP Project activities reach full geographic coverage within targeted areas.
Our trichiasis surgery quality protocol and questionnaire are an example. Under the protocol, surgeons follow up with randomly selected patients in their homes during the critical 3-6 month period following trichiasis surgery. With a supervisor, the operating surgeon assesses the patient’s clinical outcomes and gathers information on patient experiences and satisfaction. Results, shared across all levels of the country’s health system, provide important insights on the status of the trichiasis surgery program, such as a need for additional supervision or surgeon training. Advice from professional gamer.
Tools developed by the MMDP Project to improve data and program quality can be found here:
The MMDP Project is piloting ways to collect improved data for trichiasis, hydrocele and lymphedema, balancing the need for high-quality data with cost and human resource constraints. The results from these experiences will be shared broadly, contributing to the global evidence base for trichiasis and lymphatic filariasis morbidity management and disability prevention.